Literature DB >> 12470826

Role of the Raf/MEK/ERK and the PI3K/Akt(PKB) pathways in fibroblast senescence.

Antonello Lorenzini1, Maria Tresini, Madhu Mawal-Dewan, Lorenza Frisoni, Hong Zhang, Robert G Allen, Christian Sell, Vincent J Cristofalo.   

Abstract

Replicative senescence is characterized by numerous phenotypic alterations including loss of proliferative capacity and numerous changes in gene expression such as impaired serum inducibility of the immediate early gene c-fos and increased expression of collagenase. Transcription of c-fos in response to mitogens depends on the activation of a multiprotein complex formed on the c-fos serum response element (SRE), which includes the transcription factors serum response factor (SRF) and ternary complex factor (TCF). TCF is activated after phosphorylation by the Extracellular signals Regulated Kinase 1 and 2 (ERK1/2), two kinases of the Raf/MEK/ERK signaling pathway. We have previously demonstrated that collagenase expression is under positive regulation by the transcription factor FKHRL1 and that this transcription factor is under negative regulation by the phosphatidylinositol 3-kinase(PI3K)/Akt(PKB) pathway. Although total activity of ERK and Akt was similar in total cell lysates from early and late passage fibroblasts our data indicate that in senescent cells neither ERK nor Akt are able to phosphorylate efficiently their nuclear targets. Our findings suggest that although they can be fully activated in the cytosol of both early and late passage cells, the Raf/MEK/ERK and the PI3K/Akt pathways, which are essential for cellular proliferation, are down regulated in the nuclei of senescent cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12470826     DOI: 10.1016/s0531-5565(02)00133-x

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  7 in total

Review 1.  Bypassing cellular senescence by genetic screening tools.

Authors:  Mar Vergel; Amancio Carnero
Journal:  Clin Transl Oncol       Date:  2010-06       Impact factor: 3.405

2.  Genetic demonstration of a redundant role of extracellular signal-regulated kinase 1 (ERK1) and ERK2 mitogen-activated protein kinases in promoting fibroblast proliferation.

Authors:  Laure Voisin; Marc K Saba-El-Leil; Catherine Julien; Christophe Frémin; Sylvain Meloche
Journal:  Mol Cell Biol       Date:  2010-04-05       Impact factor: 4.272

3.  Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation.

Authors:  Chi-Hwa Wu; Jan van Riggelen; Alper Yetil; Alice C Fan; Pavan Bachireddy; Dean W Felsher
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-30       Impact factor: 11.205

4.  Transcriptional regulation of the Drosophila catalase gene by the DRE/DREF system.

Authors:  So Young Park; Young-Shin Kim; Dong-Jin Yang; Mi-Ae Yoo
Journal:  Nucleic Acids Res       Date:  2004-02-24       Impact factor: 16.971

Review 5.  Disruptive chemicals, senescence and immortality.

Authors:  Amancio Carnero; Carmen Blanco-Aparicio; Hiroshi Kondoh; Matilde E Lleonart; Juan Fernando Martinez-Leal; Chiara Mondello; A Ivana Scovassi; William H Bisson; Amedeo Amedei; Rabindra Roy; Jordan Woodrick; Annamaria Colacci; Monica Vaccari; Jayadev Raju; Fahd Al-Mulla; Rabeah Al-Temaimi; Hosni K Salem; Lorenzo Memeo; Stefano Forte; Neetu Singh; Roslida A Hamid; Elizabeth P Ryan; Dustin G Brown; John Pierce Wise; Sandra S Wise; Hemad Yasaei
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

Review 6.  Inhibition of adenylyl cyclase type 5 increases longevity and healthful aging through oxidative stress protection.

Authors:  Stephen F Vatner; Ronald E Pachon; Dorothy E Vatner
Journal:  Oxid Med Cell Longev       Date:  2015-04-07       Impact factor: 6.543

7.  NKG2D ligands mediate immunosurveillance of senescent cells.

Authors:  Adi Sagiv; Dominick G A Burton; Zhana Moshayev; Ezra Vadai; Felix Wensveen; Shifra Ben-Dor; Ofra Golani; Bojan Polic; Valery Krizhanovsky
Journal:  Aging (Albany NY)       Date:  2016-02       Impact factor: 5.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.